Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 391475, 27 pages
http://dx.doi.org/10.1155/2015/391475
Research Article

Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma

1Laboratory of Control and Systems Biology, Department of Electrical Engineering, National Tsing Hua University, Hisnchu 30013, Taiwan
2Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu 31040, Taiwan
3Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan

Received 27 February 2015; Revised 23 April 2015; Accepted 23 April 2015

Academic Editor: Zheng Li

Copyright © 2015 Yung-Hao Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. N. Seyfried and L. M. Shelton, “Cancer as a metabolic disease,” Nutrition & Metabolism, vol. 7, article 7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Preziosi, Cancer Modelling and Simulation, Chapman & Hall/CRC, Boca Raton, Fla, USA, 2003.
  5. E. Barillot, Computational Systems Biology of Cancer, Taylor & Francis, Boca Raton, Fla, USA, 2013.
  6. A. Cesario and F. B. Marcus, Cancer Systems Biology, Bioinformatics and Medicine: Research and Clinical Applications, Springer, Dordrecht, The Netherlands, 2011.
  7. E. Wang, Cancer Systems Biology, CRC Press, Boca Raton, Fla, USA, 2010.
  8. Q. Yan, Systems Biology in Drug Discovery and Development: Methods and Protocols, Humana Press, New York, NY, USA, 2010.
  9. H.-F. Juan and H.-C. Huang, Systems Biology: Applications in Cancer-Related Research, World Scientific, River Edge, NJ, USA, 2012.
  10. C.-W. Li, Y. Chu, and B. Chen, “Construction and clarification of dynamic gene regulatory network of cancer cell cycle via microarray data,” Cancer Informatics, vol. 2, pp. 223–241, 2006. View at Google Scholar
  11. L.-H. Chu and B.-S. Chen, “Comparisons of robustness and sensitivity between cancer and normal cells by microarray data,” Cancer Informatics, vol. 6, pp. 165–181, 2008. View at Google Scholar · View at Scopus
  12. L.-H. Chu and B.-S. Chen, “Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets,” BMC Systems Biology, vol. 2, article 56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-C. Wang and B.-S. Chen, “A network-based biomarker approach for molecular investigation and diagnosis of lung cancer,” BMC Medical Genomics, vol. 4, article 2, 2011. View at Publisher · View at Google Scholar
  14. C.-T. Tu and B.-S. Chen, “New measurement methods of network robustness and response ability via microarray data,” PLoS ONE, vol. 8, no. 1, Article ID e55230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. H. Wong, R.-H. Chen, and B.-S. Chen, “Core and specific network markers of carcinogenesis from multiple cancer samples,” Journal of Theoretical Biology, vol. 362, pp. 17–34, 2014. View at Publisher · View at Google Scholar
  16. Y. Wong, C. Li, and B. Chen, “Evolution of network biomarkers from early to late stage bladder cancer samples,” BioMed Research International, vol. 2014, Article ID 159078, 23 pages, 2014. View at Publisher · View at Google Scholar
  17. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. F. Altekruse, K. A. McGlynn, and M. E. Reichman, “Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005,” Journal of Clinical Oncology, vol. 27, no. 9, pp. 1485–1491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Li, Z.-Y. Tang, and J.-X. Hou, “Hepatocellular carcinoma: insight from animal models,” Nature Reviews Gastroenterology and Hepatology, vol. 9, no. 1, pp. 32–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. U. Marquardt, P. R. Galle, and A. Teufel, “Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies,” Journal of Hepatology, vol. 56, no. 1, pp. 267–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. N. Aravalli, E. N. K. Cressman, and C. J. Steer, “Cellular and molecular mechanisms of hepatocellular carcinoma: an update,” Archives of Toxicology, vol. 87, no. 2, pp. 227–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. B. C. Sun and M. Karin, “Obesity, inflammation, and liver cancer,” Journal of Hepatology, vol. 56, no. 3, pp. 704–713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Villanueva, V. Hernandez-Gea, and J. M. Llovet, “Medical therapies for hepatocellular carcinoma: a critical view of the evidence,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 1, pp. 34–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zhang, S. Wang, D. Li et al., “A systems Biology-Based classifier for hepatocellular carcinoma diagnosis,” PLoS ONE, vol. 6, no. 7, Article ID e22426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Q. Zhang, X. Guo, D. Wang et al., “A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma,” Scientific Reports, vol. 4, Article ID 04154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. L. A. D'Alessandro, R. Meyer, and U. Klingmüller, “Hepatocellular carcinoma: a systems biology perspective,” Frontiers in Physiology, vol. 4, article 28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Chen, R. Liu, Z.-P. Liu, M. Li, and K. Aihara, “Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers,” Scientific Reports, vol. 2, article 342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Liu, X. Wang, K. Aihara, and L. Chen, “Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers,” Medicinal Research Reviews, vol. 34, no. 3, pp. 455–478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Liu, X. Yu, X. Liu, D. Xu, K. Aihara, and L. Chen, “Identifying critical transitions of complex diseases based on a single sample,” Bioinformatics, vol. 30, no. 11, pp. 1579–1586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-C. Wang and B.-S. Chen, “A network-based biomarker approach for molecular investigation and diagnosis of lung cancer,” BMC Medical Genomics, vol. 4, article 2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. K.-Q. Liu, Z.-P. Liu, J.-K. Hao, L. Chen, and X.-M. Zhao, “Identifying dysregulated pathways in cancers from pathway interaction networks,” BMC Bioinformatics, vol. 13, no. 1, article 126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Chatr-Aryamontri, B.-J. Breitkreutz, S. Heinicke et al., “The BioGRID interaction database: 2013 update,” Nucleic Acids Research, vol. 41, no. 1, pp. D816–D823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Bland and D. G. Altman, “Multiple significance tests: the Bonferroni method,” British Medical Journal, vol. 310, article 170, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Johansson, System Modeling and Identification, Prentice Hall, 1993.
  35. M. Pagano and K. Gauvreau, Principles of Biostatistics, 2000.
  36. M. Kanehisa, “Molecular network analysis of diseases and drugs in KEGG,” Methods in Molecular Biology, vol. 939, pp. 263–275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J.-I. Satoh, “Molecular network of microRNA targets in Alzheimer's disease brains,” Experimental Neurology, vol. 235, no. 2, pp. 436–446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Wang, Q. Huang, Z.-P. Liu et al., “NOA: a novel Network Ontology Analysis method,” Nucleic Acids Research, vol. 39, no. 13, article e87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Zhang, J. Wang, K. Hanspers, D. Xu, L. Chen, and A. R. Pico, “NOA: a cytoscape plugin for network ontology analysis,” Bioinformatics, vol. 29, no. 16, pp. 2066–2067, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. G. H. Williams and K. Stoeber, “The cell cycle and cancer,” Journal of Pathology, vol. 226, no. 2, pp. 352–364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Lu, M.-L. He, L. Wang et al., “miR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2,” Cancer Research, vol. 71, no. 1, pp. 225–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K.-F. Cheung, J. Zhao, Y. Hao et al., “CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth,” Cancer, vol. 119, no. 6, pp. 1217–1226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Dituri, A. Mazzocca, L. Lupo et al., “PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma,” International Journal of Cancer, vol. 130, no. 11, pp. 2505–2513, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Furuta, K.-I. Kozaki, K. Tanimoto et al., “The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma,” PLoS ONE, vol. 8, no. 3, Article ID e60155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Zhang, Y. Guo, B. Li et al., “Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods,” European Journal of Medical Research, vol. 18, article 35, 2013. View at Google Scholar
  48. M.-E. Terret, A. Chaigne, and M.-H. Verlhac, “Mouse oocyte, a paradigm of cancer cell,” Cell Cycle, vol. 12, no. 21, pp. 3370–3376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Macheret and T. D. Halazonetis, “DNA replication stress as a hallmark of cancer,” Annual Review of Pathology: Mechanisms of Disease, vol. 10, no. 1, pp. 425–448, 2015. View at Publisher · View at Google Scholar
  50. L. Ma, J. Teruya-Feldstein, and R. A. Weinberg, “Tumour invasion and metastasis initiated by microRNA-10b in breast cancer,” Nature, vol. 449, no. 7163, pp. 682–688, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Gao, A.-Y. Xing, G.-Y. Zhou et al., “The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer,” Oncogene, vol. 32, no. 4, pp. 491–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Negrini, V. G. Gorgoulis, and T. D. Halazonetis, “Genomic instability—an evolving hallmark of cancer,” Nature Reviews Molecular Cell Biology, vol. 11, pp. 220–228, 2010. View at Google Scholar
  53. J. J. Hornberg, F. J. Bruggeman, H. V. Westerhoff, and J. Lankelma, “Cancer: a systems biology disease,” BioSystems, vol. 83, no. 2-3, pp. 81–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Soussi, Y. Legros, R. Lubin, K. Ory, and B. Schlichtholz, “Multifactorial analysis of p53 alteration in human cancer: a review,” International Journal of Cancer, vol. 57, no. 1, pp. 1–9, 1994. View at Google Scholar · View at Scopus
  55. H. Ueda, S. J. Ullrich, J. D. Gangemi et al., “Functional inactivation but not structural mutation of p53 causes liver cancer,” Nature Genetics, vol. 9, no. 1, pp. 41–47, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Fujimoto, Y. Totoki, T. Abe et al., “Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators,” Nature Genetics, vol. 44, no. 7, pp. 760–764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. M. S. Jurica and M. J. Moore, “Pre-mRNA splicing: awash in a sea of proteins,” Molecular Cell, vol. 12, no. 1, pp. 5–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. Zhou, L. J. Licklider, S. P. Gygi, and R. Reed, “Comprehensive proteomic analysis of the human spliceosome,” Nature, vol. 419, no. 6903, pp. 182–185, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. R. S. Pillai, M. Grimmler, G. Meister et al., “Unique Sm core structure of U7 snRNPs: assembly by a specialized SMN complex and the role of a new component, Lsm11, in histone RNA processing,” Genes and Development, vol. 17, no. 18, pp. 2321–2333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Agranat-Tamir, N. Shomron, J. Sperling, and R. Sperling, “Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome,” Nucleic Acids Research, vol. 42, no. 7, pp. 4640–4651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Kaida, H. Motoyoshi, E. Tashiro et al., “Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA,” Nature Chemical Biology, vol. 3, no. 9, pp. 576–583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Kotake, K. Sagane, T. Owa et al., “Splicing factor SF3b as a target of the antitumor natural product pladienolide,” Nature Chemical Biology, vol. 3, no. 9, pp. 570–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. R. J. van Alphen, E. A. C. Wiemer, H. Burger, and F. A. L. M. Eskens, “The spliceosome as target for anticancer treatment,” British Journal of Cancer, vol. 100, no. 2, pp. 228–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Tian, H. Cheng, Z. Wang et al., “Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 4209–4225, 2015. View at Publisher · View at Google Scholar
  65. Y. Huang, X. Yang, F. Zhao et al., “Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence,” Medical Oncology, vol. 31, no. 7, pp. 1–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. A. L. P. Whitley, C. San Jose, N. Hernandez et al., A Comparison of Next Generation Sequencing and Microarrays for Transcriptome Expression Profiling, Life Technologies, 2009.